Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method

Development and Validation of Atazanavir and Ritonavir Determination in Human Plasma by HPLC-MS Method

Introduction. HIV infection is one of the most relevant diseases from a medical, epidemiological and social point of view. Timely diagnosis, detection and control of the disease, adequate prescription of antiretroviral therapy can sufficiently reduce the viral load on the patient's body, reduce...

Full description

Bibliographic Details
Main Authors:	T. N. Komarov, I. E. Shohin, O. A. Miskiv, D. S. Bogdanova, A. V. Aleshina, Yu. V. Medvedev, N. S. Bagaeva
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2020-02-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	atazanavir ritonavir plasma hplc-ms determination validation
Online Access:	https://www.pharmjournal.ru/jour/article/view/761

Similar Items

Development and Validation of Salbutamol, Bromhexine, Ambroxol and Guauaifenesin Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2019-11-01)

Liver Profile of Atazanavir/Ritonavir in Pregnant Albino Rats
by: Elias Adikwu, et al.
Published: (2019-10-01)

Development and Validation of Tadalafil Determination in Human Plasma by HPLC-MS Method
by: D. S. Bogdanova, et al.
Published: (2019-05-01)

Chemical and Toxicological Analysis of Antiretroviral Drugs
by: T. N. Komarov, et al.
Published: (2019-11-01)

Development and Validation of Pomalidomide Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2020-11-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-MS/MS Method
by: T. N. Komarov, et al.
Published: (2021-02-01)

Serum Lipid Profiles of Patients Taking Efavirenz-Based Antiretroviral Regimen Compared to Ritonavir-Boosted Atazanavir with an Optimized Background at Zewditu Memorial Hospital, Addis Ababa, Ethiopia
by: Muche Belete A, et al.
Published: (2021-02-01)

Development and Validation of Tranexamic Acid Determination in Human Plasma by HPLC-MS/MS method
by: A. V. Aleshina, et al.
Published: (2021-05-01)

Development and Validation of Valganciclovir and its Active Metabolite Ganciclovir Determination in Human Plasma by HPLC-UV Method
by: T. N. Komarov, et al.
Published: (2020-05-01)

Related factors to atazanavir plasma levels in a cohort of HIV positive individuals with undetectable viral load
by: Ana Júlia Luz, et al.

Development and validation of a stability-indicating RP–HPLC method for estimation of atazanavir sulfate in bulk
by: S. Dey, et al.
Published: (2017-04-01)

A cross-sectional study to evaluate second line virological failure and elevated bilirubin as a surrogate for adherence to atazanavir/ritonavir in two urban HIV clinics in Lilongwe, Malawi
by: Dennis Miyoge Ongubo, et al.
Published: (2017-07-01)

Comparison of atazanavir/ritonavir and darunavir/ritonavir based antiretroviral therapy for antiretroviral naïve patients
by: Tony Antoniou, et al.
Published: (2017-04-01)

Efficacy and safety of nitazoxanide plus atazanavir/ritonavir for the treatment of moderate to severe COVID-19 (NACOVID): A structured summary of a study protocol for a randomised controlled trial
by: Adeniyi Olagunju, et al.
Published: (2021-01-01)

Development and validation of a UPLC-MS method for determination of atazanavir sulfate by the “analytical quality by design” approach
by: Saha Chandni, et al.
Published: (2020-03-01)

A nucleoside-sparing regimen of dolutegravir plus ritonavir-boosted atazanavir in HIV-1-infected patients with virological failure: the DOLATAV study
by: Spagnuolo V, et al.
Published: (2019-01-01)

Hyperbilirubinemia in atazanavir treated HIV-infected patients: the impact of the UGT1A1*28 allele
by: Panagopoulos P, et al.
Published: (2017-06-01)

An observational study in an urban Ugandan clinic comparing virological outcomes of patients switched from first-line antiretroviral regimens to second-line regimens containing ritonavir-boosted atazanavir or ritonavir-boosted lopinavir
by: Eva Agnes Odongpiny Laker, et al.
Published: (2019-03-01)

Registro, incorporação tecnológica e produção pública de medicamento: estudo sobre o atazanavir | Registration, technology adoption and public production of a medicine: study of atazanavir
by: Carla Cristina de Freitas da Silveira, et al.
Published: (2016-08-01)

Study of atazanavir-induced hyperbilirubinemia among HIV patients on second-line anti-retroviral therapy
by: K Ravi, et al.
Published: (2020-01-01)

DETERMINATION OF CAPECITABINE AND ITS ACTIVE METABOLITE 5-FLUOROURACIL IN BLOOD PLASMA BY HPLC-MS/MS
by: E. S. Melnikov, et al.
Published: (2019-01-01)

Hyperbilirubinemia in atazanavir-treated human immunodeficiency virus-infected patients: the impact of the UGT1A1*28 allele
by: Naidoo A, et al.
Published: (2017-08-01)

Using the SPE and Micro-HPLC-MS/MS Method for the Analysis of Betalains in Rat Plasma after Red Beet Administration
by: Tomasz Sawicki, et al.
Published: (2017-12-01)

Evaluating the role of atazanavir/cobicistat and darunavir/cobicistat fixed-dose combinations for the treatment of HIV-1 infection
by: Crutchley RD, et al.
Published: (2016-03-01)

The strategy of pharmaceutical patent protection: the case of atazanavir
by: Carla Cristina de Freitas da Silveira, et al.
Published: (2016-03-01)

PLANNING AND EVALUATION OF BIOEQUIVALENCE STUDIES OF ATAZANAVIR PRODUCTS
by: N. E. Uvarova, et al.
Published: (2018-12-01)

HPLC-MS/MS Method for Quantitation of Sildenafil and Its Active Metabolite in Human Plasma
by: G. G. Rodionov, et al.
Published: (2020-09-01)

Determination of fenticonazole in human plasma by HPLC–MS/MS and its application to pharmacokinetic studies
by: Weixing Mao, et al.
Published: (2017-02-01)

Registro, incorporação tecnológica e produção pública de medicamento: estudo sobre o atazanavir
by: Carla Cristina de Freitas da Silveira, et al.
Published: (2016-08-01)

Registro, incorporação tecnológica e produção pública de medicamento: estudo sobre o atazanavir
by: Carla Cristina de Freitas da Silveira, et al.
Published: (2016-08-01)

Registro, incorporação tecnológica e produção pública de medicamento: estudo sobre o atazanavir
by: Carla Cristina de Freitas da Silveira, et al.
Published: (2016-08-01)

Indinavir and atazanavir; comparison of predicted property by chemoinformatics technique and implication on renal problem in HIV infected patients
by: Beuy Joob, et al.
Published: (2017-01-01)

Associação entre os níveis plasmáticos de atazanavir e a função renal
by: Luz, Ana Júlia Bretanha
Published: (2012)

Associação entre os níveis plasmáticos de atazanavir e a função renal
by: Luz, Ana Júlia Bretanha
Published: (2012)

Associação entre os níveis plasmáticos de atazanavir e a função renal
by: Luz, Ana Júlia Bretanha
Published: (2012)

HPLC-UV and GC-MS Methods for Determination of Chlorambucil and Valproic Acid in Plasma for Further Exploring a New Combined Therapy of Chronic Lymphocytic Leukemia
by: Katarzyna Lipska, et al.
Published: (2021-05-01)

Validation of a Robust and High-Throughput HPLC-MS/MS Method to Determine Amantadine Levels in Human Plasma
by: Kai Wang, et al.
Published: (2018-04-01)

Development and Validation of a HPLC-MS/MS Method for Simultaneous Determination of Twelve Bioactive Compounds in Epimedium: Application to a Pharmacokinetic Study in Rats
by: Mengjie Sun, et al.
Published: (2018-05-01)

DEVELOPMENT AND VALIDATION OF MOXIFLOXACIN DETERMINATION IN HUMAN PLASMA BY HPLC-UV METHOD
by: T. N. Komarov, et al.
Published: (2019-01-01)

Simultaneous determination of plasma lopinavir and ritonavir by chemometrics-assisted spectrophotometry and comparison with HPLC method
by: Chutima Matayatsuk Phechkrajang
Published: (2013-06-01)